2025 MLS Washington DC
Event Ended
This event has ended. Registration is no longer available.
Event Schedule
Event Overview
This one-day, high-impact multidisciplinary conference will deliver a cutting-edge update on the latest advances in thoracic oncology, with a focus on the evolving landscape of lung cancer care. Key topics will include: Innovations in lung cancer screening and interventional pulmonary techniques The expanding role of social media and artificial intelligence in thoracic oncology practice Multidisciplinary strategies for managing early-stage, locally advanced, and metastatic non-small cell and small cell lung cancers Breakthrough therapies, including targeted treatments, immunotherapy, and novel systemic options Each session will feature expert-led presentations followed by interactive panel discussions, offering attendees ample opportunity to engage directly with faculty during frequent Q&A segments. To further enrich the educational experience, interactive debates and case studies presented by fellows will foster practical, peer-driven learning. Participants will also receive on-demand access to presentation materials for continued review after the event.
Instructions for Credit
Thank you for attending this conference. Your feedback is valuable to us.
To receive your Certificate of Attendance, complete and submit the Evaluation Form. Once this form is submitted your certificate will be available for download.
Registered attendees can earn a maximum of 6.75 CME/ABIM MOC/CE credits. You will be able to select the amount of credits being claimed.
Physicians: If you would like to earn MOC credit please complete the Post-Test prior to submitting the evaluation. Once submitted, you will not be able to go back to complete the Post-Test. In order for MEC to report your MOC credit, your ABIM Diplomate ID number and date of birth (mm/dd/yyyy) MUST be included in your MyMedflix user profile. A completed evaluation and passing score of 70% on the post-test is required. You will have (3) attempts to pass the test.
For questions regarding credit for this activity, please contact MEC at info@meccinc.com. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Credits
- AMA PRA Category 1 Credit™6.75
Event Details
- Duration
- 6.75 hours
- Start Date
- September 27th, 2025 7:00 AM (EDT)Central: September 27th, 2025 6:00 AMMountain: September 27th, 2025 5:00 AMPacific: September 27th, 2025 4:00 AM
- End Date
- September 27th, 2025 4:30 PM (EDT)Central: September 27th, 2025 3:30 PMMountain: September 27th, 2025 2:30 PMPacific: September 27th, 2025 1:30 PM
Objectives
Upon completion of this activity, participants should be able to: Summarize the latest evidence and recommendations in lung cancer screening, including advances in early detection methods. Describe the evolving role of interventional pulmonary procedures in the diagnosis and management of lung cancer. Evaluate emerging applications of artificial intelligence and social media in improving lung cancer care delivery, education, and patient engagement. Analyze the multidisciplinary treatment strategies for non-small cell lung cancer (NSCLC), including surgical resection, neoadjuvant/adjuvant therapies, targeted treatments, immunotherapy, and novel systemic therapies. Discuss current updates in the therapeutic landscape for small cell lung cancer (SCLC), with a focus on integration into clinical practice.
Target Audience
This educational activity has been designed to address the learning needs of a diverse oncology care team, including physicians, nurses, nurse practitioners, physician associates, pharmacists, residents, fellows, and other health care professionals involved in the diagnosis, treatment, and management of patients with lung cancer.
Faculty & Disclosure
Faculty
No Faculty or Disclosure
Disclosure
No Faculty or Disclosure
Accreditation
In support of improving patient care, The Medical Educator Consortium is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician
The Medical Educator Consortium designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
“Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit."
Learner participation will be shared through the ACCME’s Program and Activity Reporting System (PARS)
Nursing
The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ toward recertification requirements from CME activities accredited by the ACCME. Nurses can submit their credit transcript to the ANCC. One AMA PRA Category 1 Credit™ is equivalent to one ANCC credit.
Physician Associate
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may claim a maximum of 6.75 Category 1 credits for completing this activity.